Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.58
+0.31 (0.52%)
Oct 15, 2025, 4:00 PM EDT - Market closed

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of $9.28 billion. The enterprise value is $9.56 billion.

Market Cap9.28B
Enterprise Value 9.56B

Important Dates

The next confirmed earnings date is Wednesday, November 5, 2025, before market open.

Earnings Date Nov 5, 2025
Ex-Dividend Date Aug 18, 2025

Share Statistics

Bio-Techne has 155.69 million shares outstanding. The number of shares has decreased by -0.66% in one year.

Current Share Class 155.69M
Shares Outstanding 155.69M
Shares Change (YoY) -0.66%
Shares Change (QoQ) -2.01%
Owned by Insiders (%) 1.10%
Owned by Institutions (%) 102.93%
Float 153.85M

Valuation Ratios

The trailing PE ratio is 129.52 and the forward PE ratio is 29.78. Bio-Techne's PEG ratio is 3.04.

PE Ratio 129.52
Forward PE 29.78
PS Ratio 7.70
Forward PS 7.29
PB Ratio 4.81
P/TBV Ratio 16.21
P/FCF Ratio 36.16
P/OCF Ratio 32.26
PEG Ratio 3.04
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.86, with an EV/FCF ratio of 37.26.

EV / Earnings 130.28
EV / Sales 7.84
EV / EBITDA 28.86
EV / EBIT 36.04
EV / FCF 37.26

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.23.

Current Ratio 3.46
Quick Ratio 2.10
Debt / Equity 0.23
Debt / EBITDA 1.25
Debt / FCF 1.73
Interest Coverage 31.17

Financial Efficiency

Return on equity (ROE) is 3.68% and return on invested capital (ROIC) is 6.83%.

Return on Equity (ROE) 3.68%
Return on Assets (ROA) 6.30%
Return on Invested Capital (ROIC) 6.83%
Return on Capital Employed (ROCE) 11.14%
Revenue Per Employee $393,431
Profits Per Employee $23,665
Employee Count3,100
Asset Turnover 0.46
Inventory Turnover 2.21

Taxes

In the past 12 months, Bio-Techne has paid $25.06 million in taxes.

Income Tax 25.06M
Effective Tax Rate 25.45%

Stock Price Statistics

The stock price has decreased by -19.29% in the last 52 weeks. The beta is 1.48, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y) 1.48
52-Week Price Change -19.29%
50-Day Moving Average 54.75
200-Day Moving Average 57.45
Relative Strength Index (RSI) 58.48
Average Volume (20 Days) 2,695,214

Short Selling Information

The latest short interest is 5.38 million, so 3.46% of the outstanding shares have been sold short.

Short Interest 5.38M
Short Previous Month 5.27M
Short % of Shares Out 3.46%
Short % of Float 3.50%
Short Ratio (days to cover) 2.19

Income Statement

In the last 12 months, Bio-Techne had revenue of $1.22 billion and earned $73.36 million in profits. Earnings per share was $0.46.

Revenue1.22B
Gross Profit 811.12M
Operating Income 265.24M
Pretax Income 98.46M
Net Income 73.36M
EBITDA 331.14M
EBIT 265.24M
Earnings Per Share (EPS) $0.46
Full Income Statement

Balance Sheet

The company has $162.19 million in cash and $444.06 million in debt, giving a net cash position of -$281.87 million or -$1.81 per share.

Cash & Cash Equivalents 162.19M
Total Debt 444.06M
Net Cash -281.87M
Net Cash Per Share -$1.81
Equity (Book Value) 1.92B
Book Value Per Share 12.38
Working Capital 432.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $287.56 million and capital expenditures -$31.01 million, giving a free cash flow of $256.55 million.

Operating Cash Flow 287.56M
Capital Expenditures -31.01M
Free Cash Flow 256.55M
FCF Per Share $1.65
Full Cash Flow Statement

Margins

Gross margin is 66.50%, with operating and profit margins of 21.75% and 6.02%.

Gross Margin 66.50%
Operating Margin 21.75%
Pretax Margin 8.07%
Profit Margin 6.02%
EBITDA Margin 27.15%
EBIT Margin 21.75%
FCF Margin 21.03%

Dividends & Yields

This stock pays an annual dividend of $0.32, which amounts to a dividend yield of 0.54%.

Dividend Per Share $0.32
Dividend Yield 0.54%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 69.57%
Buyback Yield 0.66%
Shareholder Yield 1.19%
Earnings Yield 0.79%
FCF Yield 2.77%
Dividend Details

Analyst Forecast

The average price target for Bio-Techne is $70.58, which is 18.46% higher than the current price. The consensus rating is "Buy".

Price Target $70.58
Price Target Difference 18.46%
Analyst Consensus Buy
Analyst Count 13
Revenue Growth Forecast (5Y) 7.49%
EPS Growth Forecast (5Y) 44.69%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Nov 30, 2022
Split Type Forward
Split Ratio 4:1

Scores

Bio-Techne has an Altman Z-Score of 11.52 and a Piotroski F-Score of 5.

Altman Z-Score 11.52
Piotroski F-Score 5